Alexander Shtil

Experimental oncology, resistance of tumors to chemotherapy and radiation therapy, medical chemistry of antitumor compounds.

1.Beniaminov A.D., Chashchina G.V., Livshits M.A., Kechko O.I., Mitkevich V.A., Mamaeva O.K., Tevyashova A.N., Shtil A.A., Shchyolkina A.K., Kaluzhny D.N. Discrimination between G/C binding sites by olivomycin A is determined by kinetics of the drug-DNA interaction. International Journal of Molecular Sciences, 2020, 21, E5299. doi:10.3390/ijms21155299

2. Ol’shevskaya V.A., Zaitsev A.V., Petrova A.S., Arkhipova A.Y., Moisenovich M.M.., Kostyukov A.A., Egorov A.E., Koroleva O.A., Golovina G.V., Volodina Y.L., Kalinina E.V., Kuzmin V.A., Sakurai Y., Tanaka H., Miyoshi N., Shtil A.A. The synthetic fluorinated tetracarboranylchlorin as a versatile antitumor photoradiosensitizer. Dyes and Pigments, 2020, doi.org/10.1016/j.dyepig.2020.108993.

3. Volodina Y.L., Tikhomirov A.S., Dezenkova L.G., Ramonova A.A., Kononova A.V., Andreeva D.V., Kaluzhny D.N., Schols D., Moisenovich M.M., Shchekotikhin A.E., Shtil A.A. Thiophene-2-carboxamide derivatives of anthraquinone: a new potent antitumor chemotype. European Journal of Medicinal Chemistry, 2021, 221, 113521. doi 10.1016/j.ejmech.2021.113521

4. Soshnikova N.V., Tatarskiy E.V., Tatarskiy V.V., Klimenko N.S., Shtil A. A., Nikiforov M.A., Georgieva S.G. PHF10 subunit of PBAF complex mediates transcriptional activation by MYC. Oncogene 2021. doi.org/10.1038/s41388-021-01994-0

5. Erokhin M., Chetverina O., Győrffy B., Tatarskiy V.V., Mogila V., Shtil A.A., Roninson I.B., Moreaux J., Georgiev P., Cavalli G., Chetverina D. Clinical correlations of Polycomb repressive complex 2 in different tumor types. Cancers, 2021, 13, 3155-3180. doi: 10.3390/cancers13133155